Prediabetic State Clinical Trial
Official title:
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
The purpose of this study is to examine whether the use of genetic test information and/or
health coaching in patient risk counseling for heart disease and diabetes affect health
behaviors and health outcomes in active-duty Air Force (ADAF), beneficiaries or dependents
and Air Force retiree patients.
Total of 400 subjects will be enrolled. They will be randomly(like flipping a coin)assigned
to 4 groups: 1)Standard risk assessment (SRA)only; 2)SRA plus genetic risk information
(SRA+G); 3)SRA plus health coaching (SRA+HC); or 4)SRA, genetic risk information, and health
coaching (SRA+G+HC). Subjects randomized to the two genetic arms will have blood collected
for testing of investigational coronary heart disease (CHD) and type 2 diabetes (T2D) risk
markers. Participants in the two groups that include health coaching will be assigned to a
trained certified health coach for a period of 6 months. The duration of the study is 12
months with 3 in person visits (baseline, 6 months and 12 months) and completion of surveys
at 6 weeks and 3 month time points.
This study will examine the impact of providing genetic CHD and T2D risk information, with or
without a supportive behavioral intervention, on promoting risk-reducing behaviors and
improving clinical outcomes. In short, using a 4-group (2X2) randomized controlled trial
(RCT) design, this study will determine whether incorporating multiple-marker genetic testing
into risk counseling for CHD and T2D, coupled with a health coaching intervention will lead
to greater changes in physical fitness, health behaviors, risk status and clinical outcomes
in active-duty Air Force (ADAF), beneficiaries or dependents and AF retiree patients (N=400).
The study will address the following task objectives:
1. Determine the main and interactive effects of multiple-marker genetic risk information
incorporated into standard CHD and T2D risk counseling (Standard Risk Assessment, or
SRA) and an established, structured telephonic health coaching intervention on health
behavior change (diet, exercise habits, smoking cessation) over 12 months, with a focus
on ADAF patients, as well as their beneficiaries and retirees.
2. Determine the main and interactive effects of genetic risk information incorporated into
standard CHD and T2D risk counseling and a telephonic health coaching intervention on
clinical outcomes (fasting blood glucose, blood pressure, BMI, LDL, triglycerides, total
cholesterol, AF composite fitness scores) over 12 months in this AF cohort.
Given the lack of RCTs on the effects of differing genetic test results, such as false
reassurance and genetic determinism, we will also pursue a third, exploratory task
objective:
3. Examine the differential effects of level of CHD and T2D genetic risk (# of risk
alleles) on behavior change (diet, exercise habits, smoking cessation) and AF fitness
scores at 12 months post baseline.
Baseline data collection: After screening and informed consent, height and weight, SBP, waist
circumference, current lab results (FPG, total cholesterol, triglycerides, LDL, HbA1c, and
HDL) and current PHA (physical health assessment) data with fitness scores ( for active duty
personnel only) will be obtained from the medical records. Subjects randomized to the two
genetic arms will have blood collected for testing of investigational CHD and T2D risk
markers.
Randomization will take place to one of the following: SRA only; SRA plus genetic risk
information (SRA+G); SRA plus health coaching (SRA+HC); or SRA, genetic risk information, and
health coaching (SRA+G+HC).
Risk Counseling Visit: Within four weeks after the baseline visit all participants will
receive risk counseling with trained provider(s) at each clinic site.
Health coaching intervention: Participants in the two groups that include health coaching
will be assigned to a trained health coach for a period of 6 months (n=200). IHC (Integrative
Health Coaching) sessions will be provided by telephone using a structure that has evolved in
multiple trials and clinical programs at Duke Integrative Medicine.
Six week, 3-, and 6-month follow-ups: At 6 weeks, 3 months and 6 months after the baseline
visit, participants will be asked to complete selected surveys online.
6month and 12 month study visits: 12 months from the baseline visit, active duty participants
will complete their annual PHA, required annual AF fitness testing; and all participants will
complete study visits at 6 and 12 months for weight, waist circumference, BP, fasting glucose
or HbA1c and lipid panels to be re-assessed. Surveys will be completed at or prior to the
final 12 month visit as well.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05424107 -
A Mediterranean Intervention on Prediabetic Children
|
N/A | |
Recruiting |
NCT02681887 -
Effect of Melatonin on Cardiometabolic Risk- FULL
|
Phase 3 | |
Completed |
NCT04088461 -
Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine
|
Phase 4 | |
Recruiting |
NCT02561377 -
Effect of Resistance Training on Metabolic Control and Outcome in Prediabetes (NMR-based Metabonomics)
|
N/A | |
Completed |
NCT02551640 -
Improving Physical Activity Through a mHealth Intervention in Cardio-metabolic Risk Patients
|
N/A | |
Completed |
NCT02678390 -
Medium Chain Triglycerides and Aerobic Exercise on Ketone Production in Women With or Without Prediabetes
|
N/A | |
Completed |
NCT02459691 -
Culturally-adapted Diabetes Prevention Lifestyle Intervention for Latinos (E-LITE Latinos)
|
N/A | |
Completed |
NCT01671293 -
Multicomponent Telecare Model for Supporting Prediabetes Patients
|
N/A | |
Completed |
NCT01479933 -
Glucose Metabolism Effects of Vitamin D Supplementation in Prediabetes
|
N/A | |
Completed |
NCT00960973 -
The Effect of Vitamin K Supplementation on Glucose Metabolism
|
Phase 4 | |
Completed |
NCT00455325 -
Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
|
Phase 2 | |
Recruiting |
NCT05123963 -
Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors
|
N/A | |
Recruiting |
NCT05340868 -
Genetics of the Acute Response to Oral Semaglutide
|
N/A | |
Recruiting |
NCT04984421 -
IMplementation of the Family Support PRogramme A Healthy School Start to Prevent OVErweight and Obesity (IMPROVE)
|
N/A | |
Recruiting |
NCT04134650 -
Effect of Low Dose Combination of Linagliptin + Metformin to Prevent Diabetes
|
Phase 3 | |
Recruiting |
NCT04131582 -
Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With Prediabetes
|
Phase 3 | |
Recruiting |
NCT05347030 -
Acupuncture for Impaired Glucose Tolerance in Overweight/Obese Population
|
N/A | |
Completed |
NCT04074148 -
Effectiveness of Diabetes Prevention Education Program on Diabetes Prevention Among Prediabetes Population in Nepal
|
N/A | |
Recruiting |
NCT05050266 -
Enhancing Mental and Physical Health of Women Veterans
|
N/A | |
Completed |
NCT02684565 -
Effects of Branch Chain Amino Acids on Glucose Tolerance in Obese Pre-Diabetic Subjects
|
N/A |